Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
2025 · The Lancet · 2 citations
https://doi.org/10.1016/s0140-6736(25)02097-5